Similar articles for PMID: 17981913

Year	Number of Results
1977	1
1984	1
2001	1
2002	1
2006	2
2007	3
2008	3
2009	8
2010	5
2011	7
2012	9
2013	5
2014	10
2015	16
2016	16
2017	13
2018	9
2019	5
2020	9
2021	4
2022	6
2023	2
2024	0

1

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Annemans L, et al. Ann Rheum Dis. 2008 Jul;67(7):960-6. doi: 10.1136/ard.2007.076232. Epub 2007 Nov 2. Ann Rheum Dis. 2008. PMID: 17981913 Free PMC article.

2

Serum urate levels and gout flares: analysis from managed care data.

Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW. Sarawate CA, et al. J Clin Rheumatol. 2006 Apr;12(2):61-5. doi: 10.1097/01.rhu.0000209882.50228.9f. J Clin Rheumatol. 2006. PMID: 16601538

3

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).

Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Bardin T, et al. Ann Rheum Dis. 2017 May;76(5):811-820. doi: 10.1136/annrheumdis-2016-209213. Epub 2016 Nov 7. Ann Rheum Dis. 2017. PMID: 27821644 Free PMC article. Clinical Trial.

4

CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.

Bakris GL, Doghramji PP, Keenan RT, Silber SH. Bakris GL, et al. Am J Med. 2014 Jan;127(1):S1. doi: 10.1016/j.amjmed.2013.11.001. Epub 2013 Nov 19. Am J Med. 2014. PMID: 24268074

5

A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.

Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R. Khanna P, et al. Postgrad Med. 2016 Jan;128(1):34-40. doi: 10.1080/00325481.2016.1113840. Epub 2015 Nov 17. Postgrad Med. 2016. PMID: 26578028

6

An open-label, 6-month study of allopurinol safety in gout: The LASSO study.

Becker MA, Fitz-Patrick D, Choi HK, Dalbeth N, Storgard C, Cravets M, Baumgartner S. Becker MA, et al. Semin Arthritis Rheum. 2015 Oct;45(2):174-83. doi: 10.1016/j.semarthrit.2015.05.005. Epub 2015 May 21. Semin Arthritis Rheum. 2015. PMID: 26190562 Free article. Clinical Trial.

7

Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.

Hughes JC, Wallace JL, Bryant CL, Salvig BE, Fourakre TN, Stone WJ. Hughes JC, et al. Ann Pharmacother. 2017 Apr;51(4):301-306. doi: 10.1177/1060028016679848. Epub 2016 Nov 24. Ann Pharmacother. 2017. PMID: 27881692

8

Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.

Singh JA, Akhras KS, Shiozawa A. Singh JA, et al. Arthritis Res Ther. 2015 May 12;17(1):120. doi: 10.1186/s13075-015-0624-3. Arthritis Res Ther. 2015. PMID: 25963969 Free PMC article.

9

Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.

Hatoum H, Khanna D, Lin SJ, Akhras KS, Shiozawa A, Khanna P. Hatoum H, et al. Postgrad Med. 2014 Mar;126(2):65-75. doi: 10.3810/pgm.2014.03.2741. Postgrad Med. 2014. PMID: 24685969

10

Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.

Cutolo M, Cimmino MA, Perez-Ruiz F. Cutolo M, et al. Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4186-4195. Eur Rev Med Pharmacol Sci. 2017. PMID: 29028079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year